Brand Reference: Celexa
| Metric | Verified Benchmark | Source |
|---|---|---|
| Citalopram Hydrobromide RxNorm Concept ID | 2556 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0290 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $24.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $4.80 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $5.80 / mo | 26 Zero-PHI Verified Patient Logs |
50:50 racemic mixture of S-citalopram and mild H1-binding R-citalopram providing gentle evening-compatible serotonergic reuptake blockade with negligible CYP2D6 inhibition.
CMS National Average Drug Acquisition Cost (NADAC) tracking places Citalopram Hydrobromide (Celexa, RxCUI 2556) at $0.0290 per unit, whereas walk-in chain pharmacies bill cash patients an average of $24.00 monthly—creating a 80% ($19.20/mo) wholesale arbitrage spread down to $4.80.
Systemic exposure to Citalopram Hydrobromide reflects 80% oral absorption kinetics and cyp2c19 and cyp3a4 n-demethylation, sustaining receptor engagement across a 35 hours half-life window (2–4 weeks affective smoothing response profile).
Dosing protocols (10 mg PO daily or 20 mg PO daily (max in age >60 or CYP2C19 poor metabolizers) or 40 mg PO daily absolute QTc ceiling) balance efficacy (82.20% patient satisfaction across 26 logs) against sexual latency (23% of reports), yawning (17% of reports), somnolence (15% of reports), with strict avoidance in doses exceeding 40 mg/day (dose-dependent qtc prolongation via didesmethylcitalopram); congenital long qt; maoi.
Across 26 verified cash-pay logs, Citalopram Hydrobromide achieves a 82.20% Worth-It rating with out-of-pocket spend averaging $5.80/mo versus $24.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 10 mg PO daily for Citalopram Hydrobromide; monthly out-of-pocket dropped to $4.50 compared with $24.00 retail.
Completed 10 weeks on Citalopram Hydrobromide (20 mg PO daily (max in age >60 or CYP2C19 poor metabolizers)). Zero notable side effects on steady dosing.
Consistent biomarker response on 40 mg PO daily absolute QTc ceiling Citalopram Hydrobromide sourced via Compounding ($5.57/mo cash pay without insurance prior authorization).